Ameliorating Effect of IFN-β and Anti-IFN-β on Coxsackievirus B3-Induced Myocarditis in Mice

Journal of Interferon Research

Volumn 5, Issue 1, 1985, Pages 137-146

  Lutton, C W ^a   Gauntt, C J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL MODEL; COXSACKIE VIRUS B3; DRUG EFFICACY; EXPERIMENTAL INFECTION; HEART; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; ANTIBODIES; CELLS, CULTURED; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HEART; INTERFERON INDUCERS; INTERFERON TYPE I; MICE; MYOCARDITIS; POLY I-C; SUPPORT, U.S. GOV'T, P.H.S.; VIRUS REPLICATION;

EID: 0021857640     PISSN: 01978357     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.1985.5.137     Document Type: Article

References (50)

1. BARON, S., DIANZANI, F., and STANTON, G.J. (1982). General considerations of the interferon system. Texas Rep. Biol. Med. 41, 1–13.
2. PREBLE, O.T. and FRIEDMAN, R.M. (1983). Biology of disease. Interferon-induced alterations in cells: relevance to viral and nonviral diseases. Lab. Invest. 49, 4–18.
3. SONNENFELD, G. and MERIGAN, T.C. (1979). The role of interferon in viral infections. Springer Seminars Immunopathol. 2, 311–317.
4. GRESSER, I., TOVEY, M.G., BANDU, M.-T., MAURY, C., and BROUTY-BOYÉ (1976). Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J. Exp. Med. 144, 1305–1315.
5. GRESSER, I, TOVEY, M.G., MAURY, C., and BANDU, M.-T. (1976). Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. J. Exp. Med. 144, 1316–1323.
6. GRESSER, I., MOREL-MAROGER, L., VERROUST, P., RIVIERE, Y., and GUILLON, J.-C. (1978). Anti-interferon globulin inhibits the development of glomerulonephritis in mice infected at birth with lymphocytic choriomeningitis virus. Proc. Natl. Acad. Sci. USA 75, 3413–3416.
7. KRIM, M. (1980). Towards tumor therapy with interferons, Part II. Interferons: In vivo effects. Blood 55, 875–884.
8. WOODRUFF, J.F. (1980). Viral myocarditis. a review. Am. J. Pathol. 101, 425–483.
9. BURCH, G.E. and GILES, T.D. (1972). The role of viruses in the production of heart disease. Am. J. Cardiol. 29, 231–240.
10. LANSDOWN, A.B.G. (1978). Viral infections and diseases of the heart. Prog. Med. Virol. 24, 70–113.
11. LEWES, D. (1976). Viral myocarditis. The Practitioner. 216, 281–287.
12. PAQUE, R.E. and GAUNTT, C.J. (1983). Cellular and humoral responses in the induction and expression of viral-induced myocarditis, in: Myocarditis: A Precursor to Cardiomyopathy. J.A. Robinson and J. O'Connell (eds.). Collamore Press D.C. Heath and Co.: New York. pp. 47–69.
13. GAUNTT, C.J., TROUSDALE, M.D., LABADIE, D.R.L., PAQUE, R.E., and NEALON, T. (1979). Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J. Med. Virol. 3, 207–220.
14. KAWAI, C., MATSUMORI, A., KUMAGAI, N., and TOKUDA, M. (1978). Experimental coxsackievirus B-3 and B-4 myocarditis in mice. Japanese Cire. J. 42, 43–47.
15. ROESING, T.G., LANDAU, B.J., and CROWELL, R.L. (1979). Limited persistence of viral antigen in coxsackievirus B-3 induced heart disease in mice. Proc. Soc. Exp. Biol. Med. 160, 382–386.
16. HUBER, S.A., JOB, L.P., AULD, K.R., and WOODRUFF, J.F. (1981). Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during coxsackievirus B-3 infection. J. Immunol. 126, 1336–1340.
17. HUBER, S.A., JOB, L.P., and WOODRUFF, J.F. (1981). Sex-related differences in the pattern of coxsackievirus B-3 induced immune spleen cell cytotoxicity against virus-infected myofibers. Infect. Immun. 32, 68–73.
18. WONG, C.Y., WOODRUFF, J.J., and WOODRUFF, J.F. (1977). Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity. J. Immunol. 118, 1159–1164.
19. WONG, C.Y., WOODRUFF, J.J., and WOODRUFF, J.F. (1977). Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. II. Characterization of effector cells and demonstration of cytotoxicity against viral infected myofibers. J. Immunol. 118, 1165–1169.
20. WOODRUFF, J.F. (1979). Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B-3 replication in target organs: Evidence for involvement of mononuclear inflammatory cells in host defense. J. Immunol. 123, 31–36.
21. HUBER, S.A., JOB, L.P., and WOODRUFF, J.F. (1980). Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. Am. J. Pathol. 98, 681–694.
22. GUDVANGEN, R.J., DUFFEY, P.S., PAQUE, R.E., and GAUNTT, C.J. (1983). Levamisole exacerbates coxsackievirus B3-induced murine myocarditis. Infect. Immun. 41, 1157–1165.
23. GAUNTT, C.J., PAQUE, R.E., TROUSDALE, M.D., GUDVANGEN, R.J., BARR, D.T., LIPOTICH, G.J., NEALON, T.J., and DUFFEY, P.S. (1983). Temperature-sensitive mutant of coxsackievirus B3 (CVB3) establishes resistance in neonatal mice which protects them during adolescence against CVB3-induced myocarditis. Infect. Immun. 39, 851–864.
24. REYES, M.P. and LERNER, A.M. (1976). Interferon and neutralizing antibody in sera of exercised mice with coxsackievirus B-3 myocarditis. Proc. Soc. Exp. Biol. Med. 151, 333–338.
25. NORRIS, D. and LOK, P.C. (1979). Coxsackievirus myocarditis: prophylaxis and therapy with an interferon stimulator. Proc. Soc. Exp. Biol. Med. 142, 133–136.
26. CHO, C.T., FENG, K.K., McCARTHY, V.P., and LENAHAN, M.F. (1982). Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer. Infect. Immun. 37, 720–727.
27. TROUSDALE, M.D., PAQUE, R.E., NEALON, T., and GAUNTT, C.J. (1979). Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect. Immun. 23, 486–495.
28. TROUSDALE, M.D., PAQUE, R.E., and GAUNTT, C.J. (1977). Isolation of coxsackievirus B3 temperature-sensitive mutants and their assignment to complementation groups. Biochem. Biophys. Res. Comm. 76, 368–375.
29. GAUNTT, C.J., TROUSDALE, M.D., LEE, J.C., and PAQUE, R.E. (1983). Preliminary characterization of coxsackievirus B3 temperature-sensitive mutants. J. Virol. 45, 1037–1047.
30. PAQUE, R.E., GAUNTT, C.J., NEALON, T.J., and TROUSDALE, M.D. (1978). Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J. Immunol. 120, 1672–1678.
31. WOODRUFF, J.F. and WOODRUFF, J.J. (1974). Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J. Immunol. 113, 1726–1734.
32. HERBERMAN, R.B. and ORTALDO, J.R. (1981). Natural killer cells: their role in defenses against disease. Science 214, 24–30.
33. SENIK, A., GRESSER, I., MAURY, C., GIDLUND, M., ORN, A., and WIGZELL, H. (1979). Enhancement by interferon of natural killer cell activity in mice. Cell. Immunol. 44, 186–200.
34. GIDLUND, M., ORN, A., WIGZELL, H., SENIK, A., and GRESSER, I. (1978). Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273, 759–761.
35. CLARK, E.A. and HARMON, R.C. (1980). Genetic control of natural cytotoxicity and hybrid resistance. Adv. Cancer Res. 31, 227–285.
36. CLARK, E.A., RUSSELL, P.H., EGGHART, M., and HORTON, M.A. (1979). Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse. Int. J. Cancer 24, 688–699.
37. BUKOWSKI, J.F., WODA, B.A., HABU, S., OKUMURA, K., and WELSH, R.M. (1983). Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131, 1531–1538.
38. BENDINELLI, M. (1982). Immunomodulation in viral infections: virus or infection-induced, in: Immuno-modulation. New Frontiers and Advances. H.H. Fudenberg, H.D. Witten, and F. Ambrogi (eds.). Plenum Press: New York. pp. 161–195.
39. MERRILL, J.E. (1983). Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E. J. Clin. Immunol. 3, 42–50.
40. TRINCHIERI, G. and SANTOLI, D. (1978). Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of suscepttbility of target cells to lysis. J. Exp. Med. 147, 1314–1333.
41. RAGER-ZISMAN, B. and BLOOM, B.R. (1982). Natural killer cells in resistance to virus-infected cells. Springer Seminars Immunopathol. 4, 397–414.
42. RODER, J.C. and PROSS, H.F. (1982). The biology of the human natural killer cell. J. Clin. Immunol. 2, 249–263
43. BIRON, C.A. and WELSH, R.M. (1982). Activation and role of natural killer cells in virus infections. Med. Microbiol. 170, 155–172.
44. BIRON, C.A. and WELSH, R.M. (1982). Blastogenesis of natural-killer cells during viral infection in vivo. J. Immunol. 129, 2788–2795.
45. HUBER, S.A., JOB, L.P., and WOODRUFF, J.F. (1984). In vitro culture of coxsackievirus group B, type 3 immune spleen cells on infected endothelial cells and biological activity of the cultured cells in vivo. Infect. Immun. 43, 567–573.
46. DEMAEYER, E. (1981). Interferon and the immune system: a review (limited to 7alpha; and β interferons), in: The Biology of the Interferon System. E. DeMaeyer, G. Galasso, and H. Schellekens (eds.). Elsevier/ North-Holland Biomedicai Press: Amsterdam, The Netherlands, pp. 203–209.
47. HOVI, T., SAKSELA, O., LINNAVUORI, K., VAHERI, A., and CANTELL, K. (1981). Activation of monocyte functions by interferons, in: The Biology of the Interferon System. E. DeMaeyer, G. Galasso, and H. Schellekens (eds.). Elsevier/North-Holland Biomedicai Press: Amsterdam, The Netherlands, pp. 217–220.
48. AUNE, T.M. and PIERCE, C.W. (1982). Activation of a suppressor T-cell pathway by interferon. Proc. Natl. Acad. Sci. USA 79, 3808–3812.
49. CROWELL, R.L. and SIAK, J.-S. (1978). Receptor for group B coxsackieviruses: characterization and extraction from HeLa cell plasma membranes, in: Perspectives in Virology. M. Pollard (ed.). Vol. 10, Chapter 4. Raven Press: New York. pp. 39–55.
50. KRAH, D.L. and CROWELL, R.L. (1982). A solid-phase assay of solubilized HeLa cell membrane receptors for binding group B coxsackieviruses and polioviruses. Virology 118, 148–156.